FundedIQ
Health Care

Orcabio: Funding, Investors & Team (Sep 2026)

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

www.orcabio.com LinkedIn Menlo Park, United States 101-250 employees
Health Care Medical Pharmaceutical
Total raised
$442M
Rounds
2
Latest
Series F
Jan 2026

Orcabio has raised $442M across 2 funding rounds on record, the most recent a Series F of $250M announced in Jan 2026.

That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

Orcabio Company Profile and Key Stats

Total funding raised
$442M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series F
$250M in Jan 2026
Employees
101-250
reported band
Headquarters
Menlo Park, United States

Latest funding round on record: Jan 2026.

Orcabio Funding Rounds

Date
Round
Amount
Series F
$250M
Undisclosed round
$192M

Orcabio raised $192M in an undisclosed round announced in Jun 2020.

5.6 years later, a Series F of $250M was announced in Jan 2026.

Orcabio Founders and Leadership Team

Name
Role
Contact
Ivan Dimov
CEO
Locked

Contact details for the Orcabio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Orcabio Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
29,722
$7.5M
89
$125M

Orcabio's latest round of $250M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Orcabio in Health Care and Menlo Park

Companies Similar to Orcabio

https://metriport.com

Series A $26.0M

There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…

Series A $17.0M

Serif Health provides healthcare price intelligence and contract management solution.

Private Equity $5.7M

Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…

Undisclosed round $5.0M

Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…

Seed $750k

TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…

Series A $10.0M

Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.

Undisclosed round $1.5M

Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…

Undisclosed round $3.0M

Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…

Series A $14.0M

Happy Health is a mission-driven technology company committed to transforming mental health awareness through…

Undisclosed round $75.0M

Leal Therapeutics creates new treatments for patients.

Series A $30.0M

Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…

Series A $18.3M

Orcabio Funding FAQs

What does Orcabio do?

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

How much funding has Orcabio raised?

Orcabio has raised $442M across 2 rounds on record. The most recent is a Series F of $250M announced in Jan 2026.

When did Orcabio last raise funding?

Orcabio's most recent funding round on record is a Series F of $250M, announced in Jan 2026.

Who is the CEO of Orcabio?

Ivan Dimov is listed as CEO at Orcabio.

Where is Orcabio headquartered?

Orcabio is based in Menlo Park, California, United States.

How many employees does Orcabio have?

Orcabio is in the 101-250 employee band.

How does Orcabio's funding compare to other Health Care startups?

Orcabio's latest round of $250M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's Orcabio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Orcabio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.